作为单疗法或与Peg-IFNα-2a结合使用布莱维尔提德作为慢性三角肝炎治疗的2期随机研究
Pietro Lampertico1,2, Pavel O Bogomolov3, Vladimir Chulanov4,5
1Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
概括
布列维尔提德 (BLV) 与基化干扰素α-2a (Peg-IFNα-2a) 结合,显示出高水平的无法检测到的型肝炎病毒RNA治疗结束后. 这种组合治疗在慢性病毒性肝炎患者中耐受良好.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝炎三角病毒 (HDV) 感染导致严重的慢性病毒性肝炎.
- 布列维 (BLV) 单一治疗显示出有益的病毒学和生化反应.
- 这项研究评估了包括BLV,特诺福维尔二氧化 fumarate (TDF) 和Peg-IFNα-2a在内的组合疗法.
研究的目的:
- 为了评估48周BLV单疗法和HDV感染的组合疗法的疗效和安全性.
- 为了评估病毒载量和乙型肝炎表面抗原 (HBsAg) 在72.周的下降.
- 为了确定72周无法检测到的HDVRNA的速率.
主要方法:
- 90名患者被随机分配到6个手臂 (A-F).
- 武器包括Peg-IFNα-2a单疗法,不同剂量的BLV加Peg-IFNα-2a,BLV单疗法和BLV加TDF.
- 主要终点是72周无法检测到的HDVRNA.
主要成果:
- 在72周,不检测到的HDVRNA率在含有BLV的手臂中从7%到53%不等,而Peg-IFNα-2a单一治疗手臂的比例为0%.
- 与A臂相比,B臂 (BLV 2mg + Peg-IFNα-2a) 的HBsAg下降或损失率显著更高 (p=0.017).
- 在BLV治疗中观察到剂量依赖的和可逆的胆酸升高.
结论:
- 与Peg-IFNα-2a结合使用的BLV耐受性良好.
- 高率的HDVRNA不可检测性在结合疗法治疗后实现.
- 基于BLV的疗法在治疗高强度病毒感染方面表现有前途.
更多相关视频
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
6.7K
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.1K
相关概念视频
01:25Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
01:28Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28